Equities

Cryoport Inc

Cryoport Inc

Actions
IndustrialsIndustrial Support Services
  • Price (USD)11.10
  • Today's Change-0.01 / -0.09%
  • Shares traded1.05m
  • 1 Year change-48.40%
  • Beta1.6395
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.

  • Revenue in USD (TTM)225.03m
  • Net income in USD-120.91m
  • Incorporated1990
  • Employees1.02k
  • Location
    Cryoport Inc112 Westwood Place, Suite 350BRENTWOOD 37027United StatesUSA
  • Phone+1 (949) 232-1900
  • Fax+1 (949) 470-2306
  • Websitehttps://www.cryoport.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CYRX:NAQ since
announced
Transaction
value
Tec4med Lifescience GmbHDeal completed02 Nov 202302 Nov 2023Deal completed16.60%--
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Protect Pharmaceutical Corporation Inc0.00-15.04k147.65m3.00---------0.0135-0.01350.00-0.13640.00-------149.88-22,566.05---------------0.0495---------193.96------
ICTS International N.V.431.54m7.08m211.12m8.26k34.19--15.930.48920.1650.16510.95-0.10882.26--6.9252,225.825.545.7444.6170.1718.5321.262.452.69--511.050.0023--32.794.56249.86---11.87--
Radiant Logistics Inc828.66m6.05m246.29m872.0042.771.2010.050.29720.12250.122517.084.382.08--6.26950,301.601.666.712.4110.5429.2324.100.79782.31----0.0096---25.625.20-53.6829.0113.52--
Flyexclusive Inc0.001.01m401.56m--43.531.88----0.11850.11850.002.750.00------0.7435--0.7741--------------0.1023------70.85------
CryoPort Inc225.03m-120.91m517.70m1.02k--1.17--2.30-2.47-2.474.609.590.2265.095.18220,834.20-11.34-13.85-11.88-14.4941.7943.87-50.17-57.5210.22--0.4471---1.7064.06-137.33--72.26--
Sky Harbour Group Corp8.87m-28.92m684.19m35.00--12.61--77.12-1.28-1.280.39590.81380.023----253,485.70-9.83---12.34-------426.95-----0.82090.5983--310.57---408.07------
Air Transport Services Group Inc.2.06bn48.23m839.29m5.10k19.870.60742.020.40840.64280.650928.2621.030.541218.109.19403,343.101.273.601.413.9752.6354.922.356.430.63272.330.55430.001.2318.33-69.58-2.5222.05--
Smartstop Self Storage Reit Inc232.90m-6.39m958.16m500.00--2.5017.704.11-0.0661-0.06612.406.700.1217----465,797.100.4168-0.83340.4487-0.891469.5667.423.42-7.38--1.050.5965--9.5723.71-151.60--68.17--
Bristow Group Inc1.33bn1.35m964.23m3.30k941.761.1711.150.72360.03610.036146.5328.910.698710.706.01404,033.100.0649--0.0764--24.22--0.0928--1.393.140.3988----42.39----54.64--
Wheels Up Experience Inc1.10bn-483.91m1.47bn2.12k--1,571.95--1.34-10.12-10.123.660.00130.759830.6614.65519,190.00-33.47---125.61--1.97---44.05--0.3554-6.190.954---20.66--12.21------
AAR Corp2.22bn60.20m2.46bn5.00k40.772.1126.191.111.701.7063.0432.971.202.896.58443,140.003.273.804.124.8119.1016.252.733.321.335.330.19046.749.372.6313.868.506.04--
Data as of Jun 07 2024. Currency figures normalised to Cryoport Inc's reporting currency: US Dollar USD

Institutional shareholders

65.94%Per cent of shares held by top holders
HolderShares% Held
Brown Capital Management LLCas of 31 Mar 20246.56m13.39%
Cadian Capital Management LPas of 31 Mar 20244.85m9.90%
Morgan Stanley & Co. LLCas of 31 Mar 20244.32m8.82%
The Vanguard Group, Inc.as of 31 Mar 20243.54m7.23%
BlackRock Fund Advisorsas of 31 Mar 20243.03m6.18%
Impax Asset Management Ltd.as of 31 Mar 20242.52m5.14%
Fred Alger Management LLCas of 31 Mar 20241.99m4.07%
Massachusetts Financial Services Co.as of 31 Mar 20241.98m4.05%
Invesco Advisers, Inc.as of 31 Mar 20241.87m3.81%
New York State Common Retirement Fundas of 31 Mar 20241.65m3.36%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.